Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem
about
Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells.Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis.Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.Selected reaction monitoring as an effective method for reliable quantification of disease-associated proteins in maple syrup urine disease.Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.A systematic model of the LC-MS proteomics pipelineThe development of selected reaction monitoring methods for targeted proteomics via empirical refinement.Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.Perspectives of targeted mass spectrometry for protein biomarker verification.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Quantitative neuroproteomics: classical and novel tools for studying neural differentiation and function.Analytical methods for 3-nitrotyrosine quantification in biological samples: the unique role of tandem mass spectrometry.Industrialized MS-based proteomics in the search for circulating biomarkers.Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications.Selected reaction monitoring applied to proteomics.Peptide and protein drug analysis by MS: challenges and opportunities for the discovery environment.Applying selected reaction monitoring to targeted proteomics.Global absolute quantification of a proteome: Challenges in the deployment of a QconCAT strategy.Current methodologies for proteomics of bacterial surface-exposed and cell envelope proteins.Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present.The application of quantification techniques in proteomics for biomedical research.Quantitative mass spectrometry for colorectal cancer proteomics.Free and total biotherapeutic evaluation in chromatographic assays: interference from targets and immunogenicity.Mass spectrometry and 3-nitrotyrosine: strategies, controversies, and our current perspective.Vitreous humor in the pathologic scope: insights from proteomic approaches.Investigating protein isoforms via proteomics: a feasibility study.Isotope dilution assay in peptide quantification: the challenge of microheterogeneity of internal standard.Fragmentation patterns of chromophore-tagged peptides in visible laser induced dissociation.Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.Adrenal steroidogenesis disruption caused by HDL/cholesterol suppression in diethylstilbestrol-treated adult male rat.
P2860
Q33685268-46659EA8-5EA1-4FAD-96AA-6B6EBC6D1054Q34133645-9E2D73AE-0E58-42D4-B8EF-427987958C17Q34292436-5CCC811E-EC73-423F-982B-BE5FA2C7124BQ34311107-F2822F0B-A596-4617-B045-DB96CC582CFFQ34333925-928B6028-EBB3-4D56-943C-5590F465107BQ34470259-0C90D444-256D-404D-B1A8-11AC2D6D6650Q36813369-82B9D110-72E9-4520-8586-6071A00BA0E8Q37187957-F60CA46C-DB87-4BE1-8CA1-D149DB226300Q37481709-34DBA815-9BEE-4AB1-92FB-6D5B96FB57D2Q37720601-6BE3F72D-446E-4187-B18F-2E9E2E22B9ACQ37721307-5825A25B-00C1-4176-B1A6-005E42C26D85Q37760069-B7D13A06-4B72-47FE-83F8-0F33A31EEFB5Q37810154-07276733-26A1-4177-81BF-C759A05425C1Q37828113-A8AE3E32-1940-4C98-99E2-E2CA4D5662A6Q37851918-81DDCC99-DBC7-4A3D-8802-5FACF98F7B02Q37854632-6639171A-6B53-47D8-8031-11A412E25BE3Q37866305-AD1EE54F-0747-4936-A392-ED94A0F70815Q37895213-E7636A2B-AEC0-49DA-921D-3064E21F0CCDQ37897206-C465B995-A623-4171-A520-44B14408AC92Q38024637-62A6F3A2-C8C8-47E3-804B-1D4BCB9F0EACQ38030883-321D5443-7DD1-4FC6-95B5-960C048AE8A9Q38048726-5D197BAC-C176-45CA-A8A6-03D84D10229FQ38054162-EF13EC63-C10E-4D0A-821A-FD88F8580ED7Q38156144-3B97178E-5DF5-451B-A30C-11BC99946110Q38293676-AC8C8D66-542B-4D74-862C-FC0A2457B2BBQ41953621-D98B50A7-83DC-446D-A2AC-0FA3157FD39AQ44072955-B402BF48-7791-449F-BF0E-9A6B2CF228BEQ47835836-38C8D529-8095-4FD1-80BE-3D791F7E3C8BQ51064892-8E816E59-310A-436C-9BC1-E2380A733B55Q52663396-002C9E7B-4223-465A-8ED1-E1A8FCE3A016
P2860
Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Quantifying proteins by mass s ...... RM is only part of the problem
@ast
Quantifying proteins by mass s ...... RM is only part of the problem
@en
Quantifying proteins by mass s ...... RM is only part of the problem
@nl
type
label
Quantifying proteins by mass s ...... RM is only part of the problem
@ast
Quantifying proteins by mass s ...... RM is only part of the problem
@en
Quantifying proteins by mass s ...... RM is only part of the problem
@nl
prefLabel
Quantifying proteins by mass s ...... RM is only part of the problem
@ast
Quantifying proteins by mass s ...... RM is only part of the problem
@en
Quantifying proteins by mass s ...... RM is only part of the problem
@nl
P2093
P2860
P356
P1433
P1476
Quantifying proteins by mass s ...... RM is only part of the problem
@en
P2093
Alfred L Yergey
Mark W Duncan
Scott D Patterson
P2860
P304
P356
10.1002/PMIC.200800739
P577
2009-03-01T00:00:00Z